Improving fatigue assessment in immune-mediated neuropathies: the modified Rasch-built fatigue severity scale
- PMID: 20021568
- DOI: 10.1111/j.1529-8027.2009.00238.x
Improving fatigue assessment in immune-mediated neuropathies: the modified Rasch-built fatigue severity scale
Abstract
Fatigue is a major disabling complaint in patients with immune-mediated neuropathies (IN). The 9-item fatigue severity scale (FSS) has been used to assess fatigue in these conditions, despite having limitations due to its classic ordinal construct. The aim was to improve fatigue assessment in IN through evaluation of the FSS using a modern clinimetric approach [Rasch unidimensional measurement model (RUMM2020)]. Included were 192 stable patients with Guillain-Barré syndrome (GBS), chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) or polyneuropathy associated with monoclonal gammopathy of undetermined significance (MGUSP). The obtained FSS data were exposed to RUMM2020 model to investigate whether this scale would meet its expectations. Also, reliability and validity studies were performed. The original FSS did not meet the Rasch model expectations, primarily based on two misfitting items, one of these also showing bias towards the factor 'walking independent.' After removing these two items and collapsing the original 7-point Likert options to 4-point response categories for the remaining items, we succeeded in constructing a 7-item Rasch-built scale that fulfilled all requirements of unidimensionality, linearity, and rating scale model. Good reliability and validity were also obtained for the modified FSS scale. In conclusion, a 7-item linearly weighted Rasch-built modified FSS is presented for more proper assessment of fatigue in future studies in patients with immune-mediated neuropathies.
Similar articles
-
Patient-Reported Outcome Measures for Assessing Health-Related Quality of Life in Patients With Polyneuropathies, Focusing on Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy: A Systematic Review of Measurement Properties.J Peripher Nerv Syst. 2025 Jun;30(2):e70022. doi: 10.1111/jns.70022. J Peripher Nerv Syst. 2025. PMID: 40366569 Free PMC article. Review.
-
Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies.Neurology. 2011 Jan 25;76(4):337-45. doi: 10.1212/WNL.0b013e318208824b. Neurology. 2011. PMID: 21263135
-
Rasch analysis of the Fatigue Severity Scale in multiple sclerosis.Mult Scler. 2009 Jan;15(1):81-7. doi: 10.1177/1352458508096215. Epub 2008 Aug 28. Mult Scler. 2009. PMID: 18755824
-
Measuring fatigue in Parkinson's disease: a psychometric study of two brief generic fatigue questionnaires.J Pain Symptom Manage. 2006 Nov;32(5):420-32. doi: 10.1016/j.jpainsymman.2006.05.021. J Pain Symptom Manage. 2006. PMID: 17085268
-
[Inflammatory polyneuropathies can be treated successfully].Lakartidningen. 2012 May 9-15;109(19):950-4. Lakartidningen. 2012. PMID: 22734259 Review. Swedish. No abstract available.
Cited by
-
Patient-Reported Outcome Measures for Assessing Health-Related Quality of Life in Patients With Polyneuropathies, Focusing on Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy: A Systematic Review of Measurement Properties.J Peripher Nerv Syst. 2025 Jun;30(2):e70022. doi: 10.1111/jns.70022. J Peripher Nerv Syst. 2025. PMID: 40366569 Free PMC article. Review.
-
Clinical outcome of CIDP one year after start of treatment: a prospective cohort study.J Neurol. 2022 Feb;269(2):945-955. doi: 10.1007/s00415-021-10677-5. Epub 2021 Jun 26. J Neurol. 2022. PMID: 34173873 Free PMC article.
-
Guillain-Barré syndrome in low-income and middle-income countries: challenges and prospects.Nat Rev Neurol. 2021 May;17(5):285-296. doi: 10.1038/s41582-021-00467-y. Epub 2021 Mar 1. Nat Rev Neurol. 2021. PMID: 33649531 Free PMC article. Review.
-
Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis.Nat Rev Neurol. 2014 Aug;10(8):469-82. doi: 10.1038/nrneurol.2014.121. Epub 2014 Jul 15. Nat Rev Neurol. 2014. PMID: 25023340 Review.
-
Withdrawal of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy.Brain. 2022 Jun 3;145(5):1641-1652. doi: 10.1093/brain/awac054. Brain. 2022. PMID: 35139161 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical